CSL ( – ) was upgraded by stock analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Tuesday, Zacks reports.
CSLLY has been the topic of several other reports. Jefferies Financial Group lowered CSL from a “strong-buy” rating to a “hold” rating in a report on Friday, May 29th. Zacks Research raised shares of CSL from a “strong sell” rating to a “hold” rating in a research note on Friday, August 7th. One analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, CSL currently has a consensus rating of “Hold”.
Get CSL alerts: Get Our Latest Research Report on CSL
CSL Stock Performance
Shares of CSL stock opened at $30.65 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.15 and a current ratio of 2.57. CSL has a twelve month low of $16.01 and a twelve month high of $36.28. The business has a 50-day moving average price of $25.97 and a 200 day moving average price of $23.34. CSL Company Profile ( Get Free Report )
CSL Limited (OTCMKTS:CSLLY) is an Australian biotechnology company that develops, manufactures and supplies medicines ...